Compounds > nandrolone
Page last updated: 2024-08-21

nandrolone and Hormone-Dependent Neoplasms

nandrolone has been researched along with Hormone-Dependent Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andò, S; Barone, I; Bonofiglio, D; Casaburi, I; Catalano, S; Chimento, A; Giordano, C; Lanzino, M; Maris, P; Morelli, C; Rizza, P; Sirianni, R; Sisci, D1
Gooderham, NJ; Koufaris, C; Powell, C; Segal, CV1
Anchoori, RK; Bakare, O; Hallur, G; Isaacs, JT; Kageyama, Y; Khan, SR; Singh, P1
Bevan, CL; Brooke, GN; Culley, RL; Dart, DA; Gamble, SC; Gaughan, L; Mann, DJ; McCracken, SR; Powell, SM; Robson, CN; Spencer-Dene, B; Wait, R; Walker, MM; Waxman, J1
Cahill, MA; Fehm, T; Mueck, AO; Neubauer, H; Ruan, X; Schneck, H; Seeger, H1
Aoki, D; Katsuki, Y; Nozawa, S; Shibutani, Y1
Bergert, ER; Castro, MR; Heufelder, AE; McIver, B; Morris, JC; Spitzweg, C; Tindall, DJ; Young, CY; Zhang, S1
Brandes, SJ; Katzenellenbogen, JA1

Reviews

1 review(s) available for nandrolone and Hormone-Dependent Neoplasms

ArticleYear
Fundamental considerations in the design of fluorine-18 labeled progestins and androgens as imaging agents for receptor-positive tumors of the breast and prostate.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1988, Volume: 15, Issue:1

    Topics: Androgens; Breast Neoplasms; Female; Fluorine Radioisotopes; Humans; Male; Nandrolone; Neoplasms, Hormone-Dependent; Progesterone; Progesterone Congeners; Prostatic Neoplasms; Protein Binding; Radionuclide Imaging; Receptors, Androgen; Receptors, Estrogen; Sex Hormone-Binding Globulin; Structure-Activity Relationship; Testosterone; Transcortin

1988

Other Studies

7 other study(ies) available for nandrolone and Hormone-Dependent Neoplasms

ArticleYear
DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation.
    Cell death & disease, 2013, Jul-11, Volume: 4

    Topics: Androgens; Apoptosis; Aromatase; Base Sequence; Breast Neoplasms; Cell Proliferation; DAX-1 Orphan Nuclear Receptor; Enzyme Repression; Estrogens; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Nandrolone; Neoplasms, Hormone-Dependent; Promoter Regions, Genetic; Receptors, Androgen; Response Elements

2013
Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
    Toxicology, 2015, Jul-03, Volume: 333

    Topics: Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Dose-Response Relationship, Drug; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Kallikreins; Ligands; Male; MicroRNAs; Nandrolone; Neoplasms, Hormone-Dependent; Nitriles; Oligonucleotide Array Sequence Analysis; Prostate-Specific Antigen; Prostatic Neoplasms; Real-Time Polymerase Chain Reaction; Receptors, Androgen; Time Factors; Tosyl Compounds

2015
Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.
    The Prostate, 2008, Oct-01, Volume: 68, Issue:14

    Topics: Androgen Antagonists; Androgen Receptor Antagonists; Cell Growth Processes; Cell Line, Tumor; Drug Design; Fluorescence Polarization; Formazans; Humans; Male; Nandrolone; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Tetrazolium Salts; Transcription, Genetic

2008
FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.
    Cancer research, 2011, Feb-01, Volume: 71, Issue:3

    Topics: Bone Neoplasms; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Down-Regulation; Humans; Immunohistochemistry; Male; Nandrolone; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; RNA-Binding Protein FUS

2011
Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:2

    Topics: Breast Neoplasms; Cell Proliferation; Clone Cells; Contraceptive Agents, Female; Drug Interactions; Estradiol; Estrogens; Female; Humans; MCF-7 Cells; Medroxyprogesterone Acetate; Membrane Proteins; Nandrolone; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Norethindrone; Osmolar Concentration; Progesterone; Progestins; Receptors, Progesterone; Recombinant Proteins

2013
Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Cancer, 1997, Jan-01, Volume: 79, Issue:1

    Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; Hormone Antagonists; Humans; Mice; Mice, SCID; Nandrolone; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured

1997
Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Cancer research, 1999, May-01, Volume: 59, Issue:9

    Topics: Adenocarcinoma; Androgens; Carrier Proteins; Cell Membrane; DNA, Complementary; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Iodides; Male; Membrane Proteins; Nandrolone; Neoplasms, Hormone-Dependent; Organ Specificity; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Symporters; Transfection; Tumor Cells, Cultured

1999